Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Scale AI is funding eight research projects focused on helping Canada respond to the ongoing COVID-19 pandemic, an investment that adds up to $3.4 million.
An unlikely team at Berkeley Lab has created a text-mining tool that may help scientists of all disciplines tame and tap the presently blinding blizzard of COVID-19 papers.
IBM has launched a blockchain-based network for healthcare organizations and government agencies looking to quickly find and hire alternative supply-chain sources during the public-health crisis set off by the COVID-19 outbreak.
For champions of AI in healthcare, the COVID-19 crisis affords an unignorable opportunity to trumpet the technology’s current contributions while directing attention to its potential for helping fight public-health crises to come.
Glioma patients typically need a biopsy so physicians can make a treatment decision, but researchers have developed a new AI algorithm that could make such biopsies unnecessary.
Researchers in Israel are working to develop a new AI-powered COVID-19 test—and they think it could be especially effective at detecting individuals who carry the virus without showing any symptoms.
Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.
The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals.
As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”
